BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang FY, Shao L, Su J, Zhang ZM. Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report. World J Clin Cases 2024; 12(3): 623-629 [PMID: 38322455 DOI: 10.12998/wjcc.v12.i3.623]
URL: https://www.wjgnet.com/2307-8960/full/v12/i3/623.htm
Number Citing Articles
1
Zimo Wang, Xiaodong Li, Weiyan Zhang, Lei Fu, Xinda Li, Xiaoyou Chen, Yu Lu, Rosemary C. She. Efficacy of carrimycin against Mycobacterium avium complex in vitro and in vivo Microbiology Spectrum 2025;  doi: 10.1128/spectrum.02422-24
2
Ethambutol/Isoniazid/RifampicinReactions Weekly 2024; 2014(1): 269 doi: 10.1007/s40278-024-61697-y
3
Luca Guarnera, Emiliano Fabiani, Giulia Falconi, Giorgia Silvestrini, Maria Luigia Catanoso, Mariadomenica Divona, Maria Teresa Voso. Acute Promyelocytic Leukemia-like AML: Genetic Perspective and Clinical ImplicationsCancers 2024; 16(24): 4192 doi: 10.3390/cancers16244192
4
Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He. Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii InfectionInfection and Drug Resistance 2024; : 3617 doi: 10.2147/IDR.S468413